Hemolytic Disease of the Newborn Associated with Anti-Jra Alloimmunization in a Twin Pregnancy: The First Case Report in Korea
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Jra is a high-frequency antigen found in all ethnic groups. However, the clinical significance of the anti-Jra antibody has remained controversial. Most studies have reported mild hemolytic disease of the newborn and fetus (HDNF) in Jra-positive patients. Recently, fatal cases of HDNF have also been reported. We report the first case of HDNF caused by anti-Jra alloimmunization in twins in Korea. A 33-yr-old nulliparous woman with no history of transfusion or amniocentesis was admitted at the 32nd week of gestation because of vaginal bleeding caused by placenta previa. Anti-Jra antibodies were detected in a routine laboratory examination. An emergency cesarean section was performed at the 34th week of gestation, and 2 premature infant twins were delivered. Laboratory examination showed positive direct antiglobulin test and Jr(a+) phenotype in the red blood cells and the presence of anti-Jra antibodies in the serum in both neonates. The infants underwent phototherapy for neonatal jaundice; this was followed by conservative management. They showed no further complications and were discharged on the 19th postpartum day. Preparative management to ensure the availability of Jr(a-) blood, via autologous donation, and close fetal monitoring must be performed even in cases of first pregnancy in Jr(a-) women. (Korean J Lab Med 2010;30:511-5)
Abstract
Jra is a high-frequency antigen found in all ethnic groups. However, the clinical significance of the anti-Jra antibody has remained controversial. Most studies have reported mild hemolytic disease of the newborn and fetus (HDNF) in Jra-positive patients. Recently, fatal cases of HDNF have also been reported. We report the first case of HDNF caused by anti-Jra alloimmunization in twins in Korea. A 33-yr-old nulliparous woman with no history of transfusion or amniocentesis was admitted at the 32nd week of gestation because of vaginal bleeding caused by placenta previa. Anti-Jra antibodies were detected in a routine laboratory examination. An emergency cesarean section was performed at the 34th week of gestation, and 2 premature infant twins were delivered. Laboratory examination showed positive direct antiglobulin test and Jr(a+) phenotype in the red blood cells and the presence of anti-Jra antibodies in the serum in both neonates. The infants underwent phototherapy for neonatal jaundice; this was followed by conservative management. They showed no further complications and were discharged on the 19th postpartum day. Preparative management to ensure the availability of Jr(a-) blood, via autologous donation, and close fetal monitoring must be performed even in cases of first pregnancy in Jr(a-) women. (Korean J Lab Med 2010;30:511-5)
참고문헌 (23)
- Daniels GL, "Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens", Vox Sang, 87, pp.304~316 (2004)
- Roback JD, "Technical manual. 16th ed", American Association of Blood Banks, 411~436 (2008)
- Nakajima H, "An example of anti-Jra causing hemolytic disease of the newborn and frequency of Jra antigen in the Japanese population", Vox Sang, 35, pp.265~267 (1978)
- Vedo M, "Anti-Jra in a Mexican American", Transfusion, 18, pp.569~ (1978)
- "Proceedings of the 23rd Annual Meeting of the American Association of Blood Banks", 1970, 86~
- Peyrard T, "Fatal hemolytic disease of the fetus and newborn associated with anti-Jra", Transfusion, 48, pp.1906~1911 (2008)
- Tritchler JE, "An example of anti-Jra", Transfusion, 17, pp.177~178 (1977)
- Orrick LR, "Jra-mediated hemolytic disease of the newborn infant", Am J Obstet Gynecol, 137, pp.135~136 (1980)
- Toy P, "Does anti-Jra cause hemolytic disease of the newborn?", Vox Sang, 41, pp.40~44 (1981)
- Takabayashi T, "Influence of maternal antibody anti-Jra on the baby: a case report and pedigree chart", Tohoku J Exp Med, 145, pp.97~101 (1985)
- Bacon J, "Case report, anti-Jra", Transfusion, 26, pp.543~544 (1986)
- Levene C, "The Jr(a-) phenotype and anti-Jra in two Beduin Arab women in Israel", Transfusion, 26, pp.119~120 (1986)
- Bellver-Pradas J, "Obstetric significance of anti-Jr(a) antibody", Am J Obstet Gynecol, 184, pp.75~76 (2001)
- Kendall AG, "Clinical importance of the rare erythrocyte antibody anti-Jra", Transfusion, 16, pp.646~647 (1976)
- Kwon MY, "Clinical significance of anti-Jra: report of two cases and review of the literature", Transfusion, 44, pp.197~201 (2004)
- Chung HJ, "Transfusion of Jra-positive red blood cells to a Jra-negative patient with anti-Jra", Korean J Blood Transfus, 18, pp.111~115 (2007)
- Arriaga F, "Fatal hemolytic disease of the fetus and newborn possibly due to anti-Jra", Transfusion, 49, pp.813~ (2009)
- Ishihara Y, "Successful treatment of extremely severe fetal anemia due to anti-Jra alloimmunization", Fetal Diagn Ther, 21, pp.269~271 (2006)
- Ogasawara K, "Characterization of Jra antibodies by monocyte phagocytosis assays and flow cytometry analysis", Acta Haematol Jpn, 53, pp.1131~1137 (1990)
- Miyazaki T, "A human monoclonal antibody to high-frequency red cell antigen Jra", Vox Sang, 66, pp.51~54 (1994)
- Nance SJ, "Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay", Transfusion, 27, pp.449~452 (1987)
- Garratty G, "Predicting the clinical significance of red cell antibodies with in vitro cellular assays", Transfus Med Rev, 4, pp.297~312 (1990)
- Kim HK, "A case report of anti-Jra in pregnant woman", Korean J Blood Transfus, 6, pp.185~188 (1995)